Hai-zhen Hui

P.R. China
Chongqing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Adjunctive Tofacitinib in Moderate-To-Severe Bullous Pemphigoid: A Single-Center Prospective Cohort Study.

Adjunctive Tofacitinib in Moderate-To-Severe Bullous Pemphigoid: A Single-Center Prospective Cohort Study.

Journal: American journal of therapeutics
Published: June 16, 2026

Successful Management of Refractory Generalized Pustular Psoriasis With Spesolimab.

Successful Management of Refractory Generalized Pustular Psoriasis With Spesolimab.

Journal: American journal of therapeutics
Published: April 04, 2025

Abrocitinib Successfully Treated Dupilumab-Resistant Patients With Rare Dominant Dystrophic Epidermolysis Bullosa With Atopic Dermatitis.

Abrocitinib Successfully Treated Dupilumab-Resistant Patients With Rare Dominant Dystrophic Epidermolysis Bullosa With Atopic Dermatitis.

Journal: American journal of therapeutics
Published: April 04, 2025

Rabson-Mendenhall syndrome presented as severe acanthosis nigricans in an infant harboring novel mutations in the INSR gene: a case report.

Rabson-Mendenhall syndrome presented as severe acanthosis nigricans in an infant harboring novel mutations in the INSR gene: a case report.

Journal: Frontiers in pediatrics
Published: October 15, 2024

Thalidomide Combined With Minocycline for Successful Treatment of Morbihan Syndrome Patients in Two Cases.

Thalidomide Combined With Minocycline for Successful Treatment of Morbihan Syndrome Patients in Two Cases.

Journal: American journal of therapeutics
Published: July 08, 2024

Postherpetic Vitiligo: A Wolf's Isotopic Response.

Postherpetic Vitiligo: A Wolf's Isotopic Response.

Journal: Indian journal of dermatology
Published: June 06, 2024

A recurrent missense mutation in the KRT16 gene causing pachyonychia congenita in a patient.

A recurrent missense mutation in the KRT16 gene causing pachyonychia congenita in a patient.

Journal: International journal of dermatology
Published: September 29, 2023

Rituximab for COVID-19 Vaccine-Associated Pemphigus Vulgaris.

Rituximab for COVID-19 Vaccine-Associated Pemphigus Vulgaris.

Journal: American journal of therapeutics
Published: March 07, 2023

Improvement of Refractory Chronic Actinic Dermatitis During Tofacitinib Treatment.

Improvement of Refractory Chronic Actinic Dermatitis During Tofacitinib Treatment.

Journal: American journal of therapeutics
Published: March 01, 2023

Subacute cutaneous lupus erythematosus after COVID-19 vaccine.

Subacute cutaneous lupus erythematosus after COVID-19 vaccine.

Journal: International journal of rheumatic diseases
Published: November 26, 2022

Camrelizumab-Associated Psoriasis.

Camrelizumab-Associated Psoriasis.

Journal: American journal of therapeutics
Published: November 21, 2022

Camrelizumab-induced reactive cutaneous capillary endothelial proliferation followed by tislelizumab-induced erythema multiforme in a patient with acute myeloid leukemia.

Camrelizumab-induced reactive cutaneous capillary endothelial proliferation followed by tislelizumab-induced erythema multiforme in a patient with acute myeloid leukemia.

Journal: International journal of dermatology
Published: November 18, 2022
Showing 1-12 of 14

Last Updated: 09/26/2026